Format

Send to

Choose Destination
World J Gastroenterol. 2005 Feb 28;11(8):1196-9.

Role of the intracellular receptor domain of gp130 (exon 17) in human inflammatory bowel disease.

Author information

1
Department of Internal Medicine II, Klinikum Grosshadern, Ludwig-Maximilians-University, Marchioninistr 15, D-81377 Munich, Germany. christoph.auernhammer@med.uni-muenchen.de

Abstract

AIM:

To study the role of the intracellular receptor domain of gp130 in human inflammatory bowel disease (IBD).

METHODS:

We amplified and sequenced the complete exon 17 of the human gp130 gene in 146 patients with IBD. According to clinical and histopathological signs, the 146 patients with IBD were classified as having Crohn's disease (n = 73) or ulcerative colitis (n = 63), or as indeterminate status (n = 10).

RESULTS:

No mutations in exon 17 of the gp130 gene could be detected in any of the 146 patients with IBD examined.

CONCLUSION:

There is no evidence that mutations in exon 17 of the gp130 gene are involved in the pathogenesis of human IBD.

PMID:
15754404
PMCID:
PMC4250713
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
Loading ...
Support Center